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Lipid metabolic disorder is a critical risk factor for metabolic syndrome, triggering debilitating diseases like obesity
and diabetes. Both obesity and diabetes are the epicenter of important medical issues, representing a major
international public health threat. Accumulation of fat in adipose tissue, muscles and liver and/or the defects in
their ability to metabolize fatty acids, results in insulin resistance. This triggers an early pathogenesis of type 2
diabetes (T2D). In mammals, lipid metabolism involves several organs, including the brain, adipose tissue, muscles,
liver, and gut. These organs are part of complex homeostatic system and communicate through hormones,
neurons and metabolites. Our study dissects the importance of mammalian Krüppel-like factors in over all energy
homeostasis. Factors controlling energy metabolism are conserved between mammals and Caenorhabditis elegans
providing a new and powerful strategy to delineate the molecular pathways that lead to metabolic disorder. The
C. elegans intestine is our model system where genetics, molecular biology, and cell biology are used to identify
and understand genes required in fat metabolism. Thus far, we have found an important role of C. elegans KLF in
FA biosynthesis, mitochondrial proliferation, lipid secretion, and β-oxidation. The mechanism by which KLF controls
these events in lipid metabolism is unknown. We have recently observed that C. elegans KLF-3 selectively acts on
insulin components to regulate insulin pathway activity. There are many factors that control energy homeostasis
and defects in this control system are implicated in the pathogenesis of human obesity and diabetes. In this review
we are discussing a role of KLF in human metabolic regulation.
Keywords: β-oxidation, C. elegans, Ce-KLF-1, Ce-KLF-3, Diabetes, Fatty acids, Fat storage, Insulin, Leptin, Krüppel-like
factors, KLF, Lipid metabolism, Metabolic syndrome, Obesity, Transcription factor, TriglyceridesIntroduction
Energy homeostasis and human diseases
Mammals possess the unique ability to store excess fat in
the form of triglycerides (TG), the primary component of
adipose tissue. Due to its homeostatic nature, energy stor-
age is tightly regulated through many signaling pathways
that integrate fat deposition with its mobilization and
utilization throughout the body. Given the number of
steps that are collectively associated with energy storage
and consumption underpins the importance of under-
standing the entire process of nutrient uptake, storage and
its distribution. This knowledge is also important because
deregulation in any step of this metabolic pathway can* Correspondence: sarwar.hashmi@rutgers.edu
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reproduction in any medium, provided the orlead to metabolic disorders such as diabetes, obesity, ath-
erosclerosis, and accelerated aging. Obesity or being over-
weight is an issue of great concern given that much of the
increase in this condition is driven by changes in nutrient
uptake, and its distribution. A concern relating to obesity
is that it raises the risk for many chronic and potentially
life-threatening illnesses, including diabetes, and heart
disease. Fat storage is central to whole body energy
homeostasis that involves multiple organs including the
brain, adipose, muscle, liver, and gut. Obesity has been
linked to diabetes and therefore, the term diabesity was
coined to describe the intimate link between diabetes and
obesity. A potentially unifying view is that insulin resis-
tance, which arises from an excess of body fat, links T2D
to obesity. Consistent with this view it has been observed
that fat deposition in insulin effector cells (liver cells,
muscle cells, and adipocytes) decreases their sensitivity tol Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nonadipose tissues promotes lipotoxicity. This toxicity can
diminish or impair the ability of pancreatic β-cells to
secrete sufficient insulin leading to an array of metabolic
changes characteristic of insulin resistant and T2D. The
primary genetic, environmental and other metabolic
factors responsible for insulin resistance are not com-
pletely understood. Insulin is a central regulator of both
energy homeostasis and glucose metabolism and has a
prominent role in liver, muscle, and fat cells.
The increased incidence of obesity and diabetes repre-
sents the biggest public health problems facing the world
today. In the United States about two-thirds of the pop-
ulations are now either overweight or obese. According
to the World Health Organization (WHO), the obesity
rates have more than doubled worldwide since 1980.
The numbers are just as staggering for diabetes. Many
years of genetic, molecular and biochemical studies have
provided evidence that energy homeostasis is maintained
by the combined action of hormonal, metabolic, physio-
logical, genetics, and neuronal system that regulate
appetite and food intake. The neuronal network of the
brain plays a critical role in the control of overall pro-
cesses of energy homeostasis. This network is somewhat
similar to a molecular circuit board which has remark-
able ability to organize varieties of circuit relationships
between signaling proteins. This collection of circuits
can sense signals from notable array of hormones, nutri-
ents and neural inputs. Recent studies by Schwartz and
his colleague [1] have provided detailed explanation of
the important events occurring in the brain to control
both body weight and glucose homeostasis. Accordingly,
brain controls nutrient related signals that regulate indi-
vidual’s desire to eat and therefore in normal condition
individuals do not eat constantly but rather regulate
their food intake to maintain energy homeostasis. Thus,
defects in this control system results in over eating
which is often associated with fat accumulation. Efforts
to understand neurochemical feedback mechanisms that
regulate human appetite and body weight have identified
two hormones, leptin and insulin that are secreted by
adipose tissue and the pancreatic beta cell respectively,
are key circulating signals in the central nervous system
(CNS) that regulates body adiposity [2]. These hormones
have been extensively characterized.
Leptin is secreted from adipose tissue, suggesting that
adipose tissue is not only the site for fat storage, but it
can also serve as an active endocrine organ with the
capacity to control energy homoeostasis. Adipose tissues
communicate with the brain and peripheral tissues by se-
creting hormones and adipokines [3-5]. These adipocyte-
derived products have important physiological roles in
several aspects of nutrient homeostasis [6-9], including
appetite and metabolism. However, these functions aremodulated by the site of the adipose tissue [10], by the size
of the adipocyte [11] and by adipocyte metabolism of glu-
cose [12]. Insulin is necessary to control glucose level in
the body, and is secreted from the pancreas in proportion
to fat mass and exerts potent effects on peripheral nutri-
ent storage. Similar to leptin, insulin causes long-term
inhibitory effects on energy intake. The causal role of se-
veral of these hormones and proteins in human metabolic
regulation has come through tissue culture, and mouse
studies. Understanding of the mechanisms governing nu-
trient uptake, storage and its utilization in human requires
a model organism in which changes in physiology or
development are associated with observable genetic modi-
fications. The worm, Caenorhabditis elegans offers a rele-
vant model to elucidate the mechanism of metabolic
regulation that matches the available mouse model.
We take advantage of the availability of Caenorhabditis
elegans model, its genomic databases, and the accessibility
of mutants associated with fat metabolism in order to
understand the molecular and genetic mechanism of
metabolic regulation in human. Because of its important
role in mammalian lipid and glucose metabolism [13-17],
we chose to study mammalian Krüppel-like zinc finger
transcription factors, KLFs in C. elegans model. Many of
the regulatory genes involved in C. elegans fat metabolism
are involved in adipocyte biology. This relatively simple
organism provides a powerful system to study the genes
with critical roles in human metabolic diseases.
Krüppel-like zinc finger transcription factors regulate
energy homeostasis
There is an elaborate network of adipogenic transcrip-
tion factors which include transcriptional activators, co-
activators and repressors that coordinate the expression
of essential proteins involved in the formation of mature
fat cells through several important signaling pathways.
On one hand these factors initiate and regulate the tran-
scriptional cascade during development of new fat cells.
These same factors also regulate the expression of essential
metabolic enzymes, signaling components, and adipokines
in the mature fat cell. By controlling these events, these
factors maintain the differentiated state by allowing fat cells
to perform their functions. The human KLF family has 17
members, which are expressed in a variety of cell types
[18-20]. Several members of mammalian KLFs including
KLF2-KLF7, KLF11, KLF14, and KLF15 have important
roles in fat metabolism [13-17]. For instance, KLF2 is
widely expressed in adipose tissue while functioning as a
negative regulator of adipogenesis. Forced expression of
KLF3 blocks adipocyte differentiation in 3 T3-L1 cell
lines through a direct association with C/ebpα pro-
moter, whereas a decrease in KLF3 prevents differenti-
ation [17]. Birsoy and colleagues [16] showed that KLF4
is a regulator of early adipogenesis induced in 3 T3-L1
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tail of insulin, glucocorticoids, and IBMX. Their data
further suggests that eliminating KLF4 activity inhibits
adipogenesis while down-regulating C/EBPβ. Most re-
cently, Lee and Colleagues [21] observed that mamma-
lian KLF4 mediates metabolic functions including food
intake and energy balance through regulation of human
ghrelin expression via binding to a KLF-responsive re-
gion in the promoter. Ghrelin is an orexigenic hormone
that is secreted from the stomach during fasting, which
stimulates the release of growth hormone from the pi-
tuitary gland and regulates both food intake and energy
balance [22,23]. While KLF15 promotes adipogenesis
by its expression in adipocytes and myocytes [24], it
also up-regulates GLUT4 in both adipose and muscle
tissues [25,26]. Human KLF14 controls many essential
genes that are linked to a range of metabolic condi-
tions including obesity, cholesterol, insulin and glucose
levels. Recently, human KLF14 has been identified as a
regulator linking obesity to the T2D; KLF14 acts as a
master trans-regulator of adipose gene expression in
T2D and HDL-cholesterol associated cis-acting eQTL
[27]. Thus KLF14 acts as a master switch controlling
processes that link changes in the behavior of subcuta-
neous fat to disorder in muscle and liver that contrib-
utes to diabetes, obesity and other conditions [27].
This indicates that small changes in one master regula-
tor gene can cause a cascade of other effects in other
genes. KLF plays key role in over all energy homeosta-
sis by its regulation of important factors involved in
food intake, fat storage and utilization. For instance,
KLF7 acts as negative regulator of adipogenesis. In the
insulin secreting cell line (HIT-T15 cells), over expres-
sion of KLF7 significantly suppressed glucose-induced
secretion of insulin and reduced the expression of
adiponectin and other adipogenesis related genes, in-
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Figure 1 The control of energy homeostasis by adiposity and nutrien
circulatory nutrients and adiposity related hormones, such as insulin and le
lipid storage and metabolism by regulating food intake, and substrate metadipogenesis [28,29]. The hormones, leptin and insulin
are known as circulating indicators of adiposity with
overlapping physiological and intracellular signaling
capabilities. KLF7 plays an important role in the patho-
genesis of T2D and it controls both leptin and insulin
to maintain energy balance.
Control of food intake and energy balance
Food intake is not only influenced by physiologic signals
for hunger and satiation but it can also be stimulated or
inhibited by internal signaling systems in order to regu-
late the energy stores. At present, we do not know much
about the detailed mechanisms that control our desire
to eat. Even though, some interesting hypothesis can be
drawn on the connections between, foods, the level of
neurotransmitter and metabolic interaction in producing
signals to the liver or brain (Figure 1). According to
Blundell [30], the main thrust for appetite are physio-
logic controls of food intake including positive and nega-
tive sensory feedback, the effects of nutrients, and the
nutrient reserves. The disruption in this control system
can leads to eating disorder. Several investigations have
linked the desire to eat with the inhibitory signals gener-
ated by the presence of food in the gastro-intestinal (GI)
tract, the flow of nutrients into blood and several other
factors. While the initiation of food intake can be
influenced by availability and taste of foods, the termin-
ation of food intake (satiation) are a biologically con-
trolled process [31] and is influenced by the size and the
regularity of food-intake [32].
Considerable interest in the physiology of food intake
was generated more than half a century ago when
Kennedy [33] suggested that food intake is reduced or
stopped by inhibitory signals generated in proportion to
body fat and acting in the brain. Subsequent report by
Gibbs et. al. [34] proposed that signals generated during






t related signals. Brain receives and integrates signals from both
ptin (A and B). In response, the brain maintains homeostasis of both
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colleagues [35] observed feeding in live rats and com-
pared this behavior in rats with chronic gastric fistulas
during a 60-minutes test period, when they were offered
liquid diet after 17 hr of food deprivation. Rats with
closed fistulas displayed a specific behavioral sequence
at the end of each meal: The rats stopped eating,
engaged in exploration for a short time, and then rested
or went to sleep. The injection of intestinal hormone
cholecystokinin (CCK), brought about the full succession
of satiety in these animals suggesting that endogenous
cholecystokinin is a satiety signal for the rat. Many
enzymes, hormones, and other factors are secreted by the
GI tract in response to food in the lumen, but only few
have a direct effect on food intake. Most of these factors
can cause meal termination leading to satiation [36].
Food-intake involves neuronal, visual, hormone recep-
tors, and many other nutritional signaling mechanisms.
Hormones and neural signals maintain energy homeo-
stasis by regulating the size of food intake. These signals
are received, transmitted and integrated by CNS, which
involves many neural circuits and transmitters (Figure 1).
Many signal transduction pathways control the mechan-
ism of satiation. Primarily however, the sensory neurons
pass the information about the status of ingested food to
the brain. This represents a class of metabolic satiety sig-
nals which may be metabolized in the peripheral tissues
or organs or may enter the brain directly via the circula-
tion. As noted by Blundell and Naslund, the consecutive
release and then de-activation of the hormones can
influence the sense of hunger and excessive eating [37]
leading to the termination of food-intake. Thus the
neuronal network controlling this episode play an
important role in over all energy consumption and, as
Erlanson-Albertsson [38] summarized, ingestion of
attractive food can offset normal appetite regulation.
Hence, in the normal sequence of events, the low nutri-
tion status sends a signal to the hypothalamus of the
brain, stimulating hunger signals, which activates their re-
ceptors. After normal food is consumed, brain feels that
body energy content is sufficient and then it passes this
information to the hypothalamus, to induce satiation.
The nervous system acting as a central command and
control system coordinates both metabolism and behav-
iors. Insulin receptors and insulin signaling proteins are
broadly distributed throughout CNS. Both hormone
receptors are expressed in neuronal cells in the brain
[39-41] and their intracellular signaling in hypothalamic
neurons may be necessary to control the size and the
distribution of fat. Insulin and leptin signaling both acti-
vate hypothalamic phosphatidylinositol 3-kinase (PI3K
pathway) signaling [2]. The relative importance of
proopiomelanocortin (POMC) or agouti-related protein
(Agrp) hypothalamic neurons is to sense and respond tochanges in the energy that is stored in the peripheral
tissue in order to control energy balance. Xu et al. [42]
developed mice model in which a fluorescent reporter
for PI3K activity was targeted to either Agrp or POMC
neurons and used 2-photon microscopy to measure
dynamic regulation of PI3K by insulin and leptin in
brain slices. They showed that leptin and insulin act in
parallel to stimulate PI3K in POMC neurons but in
opposite ways on Agrp neurons suggesting that the
effects of leptin and insulin are integrated by anorexi-
genic neurons [42].
Leptin is an essential regulator of food intake
The discovery of leptin in 1994 brought about an
entirely new physiological system with direct implica-
tions for the pathophysiology of human obesity and has
helped develop treatments for obesity as well as other
metabolic conditions, such as diabetes (see review
[7,43-46]). The effect of leptin mutation was first ob-
served in 1950 in obese mice that occurred at random
within a mouse colony at the Jackson Laboratory
(Maine, USA). Those mice were enormously obese and
several strains of them were found to be homozygous
for single-gene mutations falling into two classes of mu-
tation: "ob/ob", mice having mutations in the gene for
the hormone leptin, and "db/db" mice with mutations in
the gene encoding leptin receptor. The ob/ob mice were
rescued by injecting leptin into these mice resulting in a
loss of their excess fat and simultaneous return to their
normal body weight. Leptin deficiency in ob/ob mice is
associated with hyperphagia, obesity as well as insulin
resistance and diabetes [47]. The ''ob'' gene is located on
human chromosome 7, is a 16 kDa adipose derived pro-
tein hormones of 167 amino acids. Although leptin and
a number of essential proteins are secreted by white adi-
pose tissue [3-5], leptin can also be produced by brown
adipose tissue, placenta, ovaries, skeletal muscle, stom-
ach, mammary epithelial cells, bone marrow, and liver.
Indeed in nature, the level of circulating leptin is directly
proportional to the total amount of body fat. Activation
of hypothalamic leptin receptors suppresses food intake
and promotes energy expenditure pathways [48,49].
Humans deficient in leptin eat abundant foods and are
extremely obese but leptin treatment of these individuals
leads to weight loss.
The physiological effects of leptin are mediated
through the hypothalamus, the expression site of OB-R
[50]. OB-R is a high affinity leptin receptor and is known
to be an important circulating signal for the regulation
of body weight. In light of previous studies showing the
role of long intracellular domain of OB-R in the intracel-
lular signal transduction initiation, Elmquist et al. [51]
examined the distributions of mRNA of leptin receptor
isoforms in the rat brain. They suggested that the
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groups involved in regulating feeding, body weight, and
neuroendocrine function. The localization of leptin
receptor in extra-hypothalamic sites in the thalamus and
cerebellum suggests that leptin may act on specific
sensory and motor systems. Whereas leptin receptors
localized in non-neuronal cells in the choroid plexus,
and blood vessels may help transport leptin into the
brain and in the clearance of leptin from the cerebro-
spinal fluid [51]. Maffei and colleague [52] noted plasma
leptin to be highly correlated with body mass index
(BMI) in rodents and in lean and obese humans. These
findings were further corroborated by studies that exam-
ined the serum leptin concentrations and the percentage
of body weight [53]. Prolonged starvation leads to a de-
crease in the level of leptin, which in turn triggers a
series of changes in nutrition, energy expenditure, and
neuroendocrine function to maintain energy homeosta-
sis. On the other hand an increase in body fat results in
increased levels of leptin, which causes a reduction in
food intake. Consistent with its role in maintaining food
intake and or body weight, a deficiency in leptin results
in substantial obesity in mouse [47] as well as in human
[54] supporting a role of leptin in energy homeostasis.
Leptin-deficient ob/ob mice are obese and have neuroen-
docrine abnormalities similar to those of starvation,
suggesting that leptin may be involved in the physiology
of starvation. Preventing the starvation-induced fall in
leptin with exogenous leptin considerably reduces the
changes in gonadal, adrenal and thyroid axes in male
mice, and prevents the starvation-induced delay in ovu-
lation in female mice. In contrast, leptin repletion during
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Figure 2 Schematic presentation of the KLF regulation of lipid metab
represents changes that occurred due to aberrant expression of klf-1 or klf-weight [55], suggesting that regulation of the neuroendo-
crine system during starvation could be the main physio-
logical role of leptin.
C. elegans: a genetic model to study metabolic regulation
We are using C. elegans to study the role of KLF in the
control of factors that play important role in mamma-
lian metabolic regulation. There are only three KLF
members (klf-1, klf-2, and klf-3) in C. elegans genome
[56-60]. We have shown that C. elegans klf-1 is an essen-
tial regulator of lipid metabolism and its loss of function
affects lipid metabolism leading to fat accumulation and
increased cell death [56]. Recently, we reported that muta-
tion in C. elegans klf-3(ok1975) accumulates large fat
droplets rich in neutral lipids in intestine; the lipid accu-
mulation is associated with increase in TG levels [57,59]
and defects in reproduction. We proposed that KLF-3
may have a considerable regulatory role in two key pro-
cesses in fat metabolism; fatty acid (FA) β-oxidation
[59] and lipoprotein assembly and secretion [60]
(Figure 2). We do not know the precise mechanism
linking klf-3 with these two processes. KLF-3 genetically
interacts with the genes encoding enzymes involved in
FA β-oxidation in mitochondria or peroxisome and FA
synthesis in cytosol, namely acyl-CoA synthetase (acs-1
and acs-2), acyl-CoA oxidase (F08A8.1 and F08A8.2), and
stearoyl-CoA desaturase (SCD, fat-7) [59]. We have also
demonstrated that Klf-3 maintains the balance of satu-
rated and monounsaturated FAs by regulating the ex-
pression of several Δ9 desaturases, which in turn
catalyze the biosynthesis of monounsaturated C16:1 and
C18:1 FAs from saturated C16:0 and C18:0 FAs. Although
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rant ratio of saturated to monounsaturated FAs. Whether
this observation is valid for the role of mammalian KLFs
in these processes is not clear. Although the role of mam-
malian KLFs in lipid transport system has not been fully
explored, it is interesting to note that mutation in klf-3 re-
duces expression of C. elegans dsc-4 and/or vit genes, the
orthologues of mammalian MTP and apoB respectively.
Both MTP and apoB are essential for mammalian lipopro-
tein assembly and transport. Mutation in both dsc-4
(qm182) and vit-5 (ok3239), results in high fat accumula-
tion in worm intestine. The recognition of dsc-4 and all vit
genes as potential targets of KLF-3 regulation prompted
us to explore their genetic interactions, given the direct
link to lipoprotein assembly and secretion pathway. We
analyzed dsc-4; klf-3 as well as vit-5; klf-3 double mutants
to study klf-3 interactions with these genes. We noticed
that the klf-3; dsc-4 double mutant have twice as much fat
as individual mutants. Perhaps a combination of defect in
lipoprotein secretion and reduced β-oxidation might ex-
plain higher fat in double mutants. Thus both dsc-4 and
klf-3 genes are likely to act together or in succession to
promote lipoprotein secretion. Eliminating vit-5 gene
activity in klf-3 mutant does not however, alter fat content
in klf-3; vit-5 double mutant, implying that both genes
function in the same pathway (un published).
Mechanism of food intake in C. elegans
Apart from vertebrate models, such as mouse and rat, the
C. elegans worm is one of the few invertebrates in which
the physiology of food intake has been extensively studied.
The worm feeds on bacteria and takes up nutrients
through pharyngeal pumping. Thus the starved animals
pump faster when re-exposed to food than well-fed ani-
mals. The C. elegans moves around on bacterial lawn but
the speed and pattern of its movement are modulated by
starvation. The mutation in tryptophan hydroxylase gene
tph-1 (the key enzyme for serotonin biosynthesis) [61]
results in reduced pumping rate while animals exposed to
excess serotonin or imipramine, a serotonin uptake inhibi-
tor, show increased pumping [62]. It is interesting to note
that the neuronal signaling mechanisms function in worm
feeding behavior acts similarly in mammalian feeding be-
havior [63]. To investigate the importance of C. elegans klf
in worm feeding behavior and relate our findings to previ-
ous feeding studies, we analyzed klf-3 (ok1975) mutant
worm. We found a profound increase in the mRNA levels
of tph-1 gene in klf-3 (ok1975) mutant suggesting that klf-
3 may negatively control the expression of tph-1. However,
in contrast to tph-1 mutant, the pharyngeal pumping as
well as food-intake is normal in klf-3 mutant [56].
Currently, we do not have any data to support whether or
not klf-3 and tph-1 interacts during food intake and/orpharyngeal pumping. The potential relationship between
klf-3 and tph-1 genes merits further investigation.
Caenorhabditis elegans passes through four larval
stages; L1, L2, L3, and L4 before reaching adulthood.
During development, C. elegans exhibits food seeking
behavior and hunts for easy to eat food. If there is no
food available, then animals can go through an alterna-
tive developmental sequence in which a resistant 'dauer'
larval form is produced at the L2 to L3 molt. Dauers can
survive extreme conditions (desiccation and lack of food)
for long periods until conditions improve and food be-
comes available, at which time they will molt and become
normal adults [64]. C. elegans uses its mechanosensory
system for navigation. Quiescent behavior in C. elegans
has been equated to satiety in mammals [65]. The
C. elegans is ready to eat when it senses the presence of
good food, the animal starts eating and stops moving,
except for short foraging excursions forwards and back-
wards. After a period of fasting, the worm begins feed-
ing again during which a sense of calmness is induced
resulting in gradual inhibition of food intake and move-
ment [66]. The sequence of food intake and inhibition in
worm probably results from satiety and perhaps regulated
by insulin and TGF-β [65]. Previous study has shown that
EGL-4 cGMP-dependent protein kinase functions down-
stream of insulin and TGF-β in sensory neurons to con-
trol quiescence in response to food intake in worm [65].
We examined the feeding behavior and movement of the
C. elegans L4 animals from a synchronized population of
klf-3 (ok1975) mutant animals and compared with the
same developmental stage of wild-type (N2 strain). We
found that mutant worms feed as wild-type but retained
more fat than wild-type [56]. We also observed that klf-3
(ok1975) mutant animals fed on regular worm diet, E. coli
OP50 had prolong resting period (period of lethargus)
than the wild-type animals. C. elegans is accompanied by
four larval stages [66] that are interrupted by periods of
inactivity called lethargus, and has been suggested to rep-
resent ‘sleep’ [67]. Although our data is preliminary it does
raise a question about the importance of klf-3 in worm’s
quiescence behavior? If so, what is the mode of action of
klf-3 in this regulatory function? We hypothesize that
prolonged quiescence could be secondary to the buildup
of fat storage, given that the loss-of-function of KLF-3
would primarily affect the functions of the intestine. The
intestines of worms are major endocrine systems and
tissues engaged in nutrient sensing and energy metabol-
ism [68]. Many studies have suggested endocrine regula-
tions of food intake and sensing [1].
Insulin plays important role in energy homeostasis and
glucose metabolism
The history of insulin discovery is very interesting.
Frederick Banting, J. R. Macleod, Charles Best, and Bertram
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the year of 1921, Banting and Best had isolated biological
sample from pancreas extracts that considerably prolonged
the lives of diabetic dogs, whose pancreas were removed so
that they would not release insulin. It is noteworthy that
soon after the successful treatment of diabetic dogs,
Banting and Best successfully treated the first human dia-
betic patient. This finding was of great significance of that
time which ultimately helped Frederick Banting and John
Macleod earn the Nobel Prize in Physiology or Medicine in
1923. Insulin is secreted by the pancreatic β-cell in response
to high blood glucose, is a major endocrine regulator of up-
take, transport, and metabolism [70]. Being an important
element of nutrition utilization, the insulin main function
in the body is to keep blood glucose within a normal range.
The elevated levels of insulin can inhibit the release and
utilization of stored body fat for energy. Insulin converts
the excess glucose into glycogen, and stores it in the liver
and muscles. The excess glucose that cannot be stored as
glycogen is converted to fat and stored in the adipose tissue.
Insulin functions in a number of signaling pathways in spe-
cific muscle and fat cells allowing these cells to increase
their ability to uptake glucose from the blood stream.
Although adipose tissue and skeletal muscle are the major
targets of insulin action, insulin effects on the CNS is
thought to control energy balance [71].
A series of neuropeptides (the melanocortin system,
neuropeptideY) and neurotransmitters (serotonin, dopa-
mine and noradrenaline) in the hypothalamus have
emerged as key participant in behavioral, physiological
and metabolic responses. The neurons expressing these
neuropeptides interact with each other and with insulin,
leptin and with several other molecules to regulate
energy uptake and its utilization [42]. There are also
food related signals transmitting to CNS through nerves
or gut-secreted peptides [72]. Bruning and collegues [73]
investigated insulin signaling in mice created with a
neuron-specific mutation of insulin receptor gene
(NITKO mice). They noted that while both male and
female NITKO mice had normal brain development, the
food intake by female mice was increased substantially.
NITKO mice of both sexes developed diet-sensitive
obesity, increased plasma leptin levels, and increased
plasma insulin level, indicating an important role for in-
sulin receptor in the regulation of energy disposal, en-
ergy metabolism and perhaps also in reproduction [73].
Studies involving tissue-specific knockouts or reconstitu-
tion of the insulin receptor in mice have shown differ-
ences in their responses; neuronal insulin receptor or
muscle insulin receptor mice mutants are obese while
fat cell insulin receptor knockout mice are lean and re-
sistant to diet induced obesity [74]. To maintain glucose
homeostasis, insulin secretion increases in response to a
weight increase or in response to food to compensatefor insulin resistance [75,76]. One hypothetical model is
that when insulin secretion is increased it acts on the
brain, where it can control further weight gain. Insulin-
stimulated glucose utilization in adipocytes is an import-
ant feature associating leptin secretion to the body fat
[77]. Although research conducted in these hormones
strongly identify their role in hypothalamus it has not
predicted about the initial steps that mediate the activity
of insulin and leptin in hypothalamic neurons.
The C. elegans provides an important research tool to
these kinds of studies because this animal comprises 302
neurons that make up the nervous system and its neural
mechanism is responsible for its chemotaxis, thermo-
taxis and mechanotransduction behavior. Apart from
neuronal circuits, there are several key chemical trans-
mitters including serotonin, acetylcholine, glutamate,
and octopamine that control feeding in C. elegans. In
addition, there are several neuropeptides, including
insulin-like peptides [78] that are known to modify the
role of these chemical transmitters in C. elegans. The
worm nervous system also regulates fat storage both in
conjunction with and independent of feeding pathways
and its neuronal network coordinates the actions of this
animal in transmitting signals between different parts of
its body.
Insulin signaling: conserved pathways in C. elegans and
humans
The human leptin has no apparent C. elegans orthologue;
however, the insulin signaling is highly conserved between
worm and human. The C. elegans genome has predicted
approximately 40 insulin-like genes [78-81]. The insulin
signaling has long been an active area of investigation in
C. elegans because of its role in lipid metabolism and aging.
Perhaps the most direct evidence of a major role for insulin
signaling in C. elegans came from the finding that mutation
in the daf-2 insulin receptor-like gene induced metabolic
changes similar to that in mammalian metabolic control by
the insulin receptor [82]. The fundamental similarities be-
tween the worm and human insulin receptors has provided
a powerful strategy to delineate the detailed genetic and
molecular pathways of worm metabolic control that could
be applied to human metabolic diseases such as obesity and
diabetes. The DAF-2 signaling allows nondauer reproduc-
tive growth which is associated with the use of food and
with small stores of fat, while in daf-2 insulin receptor
mutant, the neuroendocrine signaling defects results in
increased fat in the intestine [82].
The research conducted in our own laboratory on
klf-3 (ok1975) mutant suggested that klf-3 is key regula-
tor of fat metabolism and its mutation disturbs fat
storage-associated signal transduction. To understand
how klf-3 regulates insulin signaling genes, we first
performed microarray analysis of klf-3 mutant. On the
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target genes to confirm their expression profiles using
RT-PCR (Figure 3). We focussed on insulin ligands, daf
components, tryptophan hydroxylase tph-1 [61], and
tub-1 [83]. We found a remarkable change in the insulin
signaling system, including its ligand (ins-1), receptor
(daf-2) and downstream effector, the FOXO-family tran-
scription factor (daf-16). Likewise, tph-1, not tub-1 was
notably increased (Figure 3). These data suggest that
KLF-3 could selectively act on these components to
regulate pathway activity and integrate their crosstalk
into the network of fat metabolism. The similarity of the
fat phenotype between the klf-3 and daf-2 mutant, and
profound effect on daf-2 or daf-16 expression in klf-3
mutant suggested that klf-3 might function with either
daf-2 or daf-16 in daf-2 (insulin/IGF-I) pathway. The
DAF-2 pathway regulates metabolism, development and
aging independently of one another. A lack of daf-2
activity causes an extension in life-span, increased fat
storage and constitutive arrest at the dauer stage [82].
Daf-16 has no obvious function during reproductive
development and its mutation daf-16(mgDf50) does not
alter fat accumulation or cause dauer arrest, while a
strong functional loss of daf-16 completely suppresses
the mutant phenotype of daf-2 [84]. Both klf-3 (ok1975)
and daf-2 (e1391) mutants accumulate extra fat. Thus to
study their genetic interaction, we created klf-3; daf-2
double mutant and assayed for fat deposition in the
mutant animals. We found that animals bearing both
klf-3 and daf-2 mutations accumulate large but similar
amounts of fat as individual mutants (data not shown)
suggesting that they are targeting the same molecular





















Figure 3 Deregulation of insulin-signaling pathway genes in C. elegan
was measured by real-time PCR. Lines at top of each bar represent standard e
relative to wild-type at scale “1”. The bar above “1” represent up-regulated, whDeletion of klf-3 created a profound effect on TGF-
β-mediated pathway as expression of several genes func-
tion in this pathway was significantly altered, linking
klf-3 with TGF-β-mediated pathway. Studies in C. elegans
have shown that DAF-7 binds DAF-1 and DAF-4 type I
and type II TGF-β receptors to promote reproductive
growth [85,86] and daf-14 acts as a transducer of the
DAF-7/TGF-β-mediated signal in this process. In daf-2,
daf-7, and tph-1 deficient worms, metabolism is shifted
towards fat accumulation [61,82,84]. Thus mutation in
either insulin or TGF-β pathway components causes large
fat deposits in worm’s intestine. C. elegans KLF-3 has essen-
tial functions required for metabolic homeostasis: not only
it regulates fat storage but intersect insulin signaling. Muta-
tion in klf-3 disrupts its regulatory roles and underlies the
chronic pathologic effects of fat accumulation on the
endocrine function of intestine. Such a link in the worm
opens up a window to look into parallel disease states in
human diabetes, i.e., obesity-conditioned insulin resistance
and lipotoxicity-induced β-cell failure.
Conclusion
In conclusion, it is clear that there are many factors that
play their unique role in fat metabolism. Dysfunction of
any of these factors results in fat accumulation in various
organs, such as adipose tissue, muscles and liver. There is
also complex interaction between food intake, environ-
mental factors, and genetics. Laboratory and clinical data
have undoubtedly explained some of the patho-physiology,
yet there are many gaps in the inclusive understanding of
human metabolic disorder. Appetite regulates body weight
by affecting and limiting food intake. Various other
biological parameters, that are sensitive to food intakenaling genes
s klf-3 (ok1975) mutant. The level of genes (designated at bottom)
rror of the measurement. Abundance of individual gene is expressed as
ile the bars below “1” represent down-regulated genes.
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fore critical in identifying the mechanism that controls food
intake. Characterizing genetic and epigenetic changes, sig-
nificant to lipid metabolism, is a big task. It is important
however to know about these genetic changes so that to
understand the mechanism of human metabolic disorder.
In this regard, the completion of genome sequence for
model organisms offers a unique opportunity to identify
the gene conservation among organisms. It permits the
analysis of genetic changes associated with human meta-
bolic disorder. Although the clinical application of model
organisms to humans remains a challenge, it may guide fur-
ther efforts to explore metabolic disorder and its relation to
obesity and diabetes. It may also provide insights to the
molecular basis of obesity and diabetes, ultimately aiding
treatments efforts of such diseases.
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